Soluble receptor for advanced glycation end products as a biomarker of symptomatic vasospasm in subarachnoid hemorrhage

View More View Less
  • 1 Departments of Neurosurgery and
  • 2 Neuroanatomy, Graduate School of Medical Sciences, Kanazawa University, Ishikawa, Japan
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

OBJECTIVE

The receptor for advanced glycation end products (RAGE) is a membrane protein associated with the induction of oxidative stress and inflammation in several pathological conditions. Previous studies have demonstrated that soluble RAGE (sRAGE) acts as a decoy for RAGE and protects cells against RAGE-mediated injury. The authors and other groups have reported that the expression of RAGE increases after brain ischemia and subarachnoid hemorrhage (SAH), and deletion of RAGE or overexpression of sRAGE improves neuronal survival. It has also been demonstrated that the plasma sRAGE level could be a predictor of the outcome after ischemic stroke. This study aimed to evaluate plasma sRAGE as a biomarker for symptomatic vasospasm (SVS) in SAH patients, as well as a rat model.

METHODS

The authors measured and compared plasma sRAGE levels in 27 SAH patients (7 with SVS and 20 without SVS) from day 5 to day 14 post-SAH. They also examined plasma sRAGE levels and expression of RAGE and heme oxygenase–1 (HO-1) in a rat SAH model.

RESULTS

The relative plasma sRAGE levels were significantly lower in the SVS group than in the non-SVS group of patients. A cut-off value of 0.84 for predicting SVS was considered to be appropriate for the relative plasma sRAGE levels on day 7 versus day 5. In the rat SAH model, plasma sRAGE levels were significantly lower than those in sham-treated rats, and the expressions of RAGE and HO-1 were enhanced in the SAH group compared with the non-SAH group.

CONCLUSIONS

Plasma sRAGE levels can be used as a potential biomarker for predicting SVS after SAH.

ABBREVIATIONS ACA = anterior cerebral artery; AGE = advanced glycation end product; cRAGE = cleaved RAGE; ELISA = enzyme-linked immunosorbent assay; esRAGE = endogenous secretory RAGE; HO-1 = heme oxygenase–1; ICA = internal carotid artery; MCA = middle cerebral artery; qRT-PCR = quantitative reverse-transcription polymerase chain reaction; RAGE = receptor for advanced glycation end products; ROC = receiver operating characteristic; SAH = subarachnoid hemorrhage; sRAGE = soluble RAGE; SVS = symptomatic vasospasm; VS = vasospasm.

Supplementary Materials

    • Supplementary Fig. 1 (PDF 1.96 MB)

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Correspondence Osamu Hori: Kanazawa University, Ishikawa, Japan. osamuh3@staff.kanazawa-u.ac.jp.

INCLUDE WHEN CITING Published online November 1, 2019; DOI: 10.3171/2019.8.JNS191269.

Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

  • 1

    Badjatia N, Topcuoglu MA, Buonanno FS, Smith EE, Nogueira RG, Rordorf GA, : Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med 33:16031609, 1623, 2005

    • Search Google Scholar
    • Export Citation
  • 2

    Barker FG II, Ogilvy CS: Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg 84:405414, 1996

    • Search Google Scholar
    • Export Citation
  • 3

    Bederson JB, Connolly ES Jr, Batjer HH, Dacey RG, Dion JE, Diringer MN, : Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 40:9941025, 2009

    • Search Google Scholar
    • Export Citation
  • 4

    Charpentier C, Audibert G, Guillemin F, Civit T, Ducrocq X, Bracard S, : Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage. Stroke 30:14021408, 1999

    • Search Google Scholar
    • Export Citation
  • 5

    Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, : RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 9:907913, 2003

    • Search Google Scholar
    • Export Citation
  • 6

    Egge A, Waterloo K, Sjøholm H, Solberg T, Ingebrigtsen T, Romner B: Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery 49:593606, 2001

    • Search Google Scholar
    • Export Citation
  • 7

    Gopal P, Reynaert NL, Scheijen JL, Schalkwijk CG, Franssen FM, Wouters EF, : Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD. Respir Res 15:24, 2014

    • Search Google Scholar
    • Export Citation
  • 8

    Gopal P, Rutten EP, Dentener MA, Wouters EF, Reynaert NL: Decreased plasma sRAGE levels in COPD: influence of oxygen therapy. Eur J Clin Invest 42:807814, 2012

    • Search Google Scholar
    • Export Citation
  • 9

    Greving JP, Wermer MJ, Brown RD Jr, Morita A, Juvela S, Yonekura M, : Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies. Lancet Neurol 13:5966, 2014

    • Search Google Scholar
    • Export Citation
  • 10

    Hirashima Y, Hamada H, Kurimoto M, Origasa H, Endo S: Decrease in platelet count as an independent risk factor for symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 102:882887, 2005

    • Search Google Scholar
    • Export Citation
  • 11

    Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, : RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97:889901, 1999

    • Search Google Scholar
    • Export Citation
  • 12

    Hop JW, Rinkel GJ, Algra A, van Gijn J: Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 28:660664, 1997

    • Search Google Scholar
    • Export Citation
  • 13

    Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen JX, : The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 270:2575225761, 1995

    • Search Google Scholar
    • Export Citation
  • 14

    Huang YH, Chung CL, Tsai HP, Wu SC, Chang CZ, Chai CY, : Hyperglycemia aggravates cerebral vasospasm after subarachnoid hemorrhage in a rat model. Neurosurgery 80:809815, 2017

    • Search Google Scholar
    • Export Citation
  • 15

    Jeon YT, Lee JH, Lee H, Lee HK, Hwang JW, Lim YJ, : The postoperative C-reactive protein level can be a useful prognostic factor for poor outcome and symptomatic vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 24:317324, 2012

    • Search Google Scholar
    • Export Citation
  • 16

    Jung CS, Lange B, Zimmermann M, Seifert V: CSF and serum biomarkers focusing on cerebral vasospasm and ischemia after subarachnoid hemorrhage. Stroke Res Treat 2013:560305, 2013

    • Search Google Scholar
    • Export Citation
  • 17

    Jung CS, Lange B, Zimmermann M, Seifert V: The CSF concentration of ADMA, but not of ET-1, is correlated with the occurrence and severity of cerebral vasospasm after subarachnoid hemorrhage. Neurosci Lett 524:2024, 2012

    • Search Google Scholar
    • Export Citation
  • 18

    Kamide T, Kitao Y, Takeichi T, Okada A, Mohri H, Schmidt AM, : RAGE mediates vascular injury and inflammation after global cerebral ischemia. Neurochem Int 60:220228, 2012

    • Search Google Scholar
    • Export Citation
  • 19

    Kellermann I, Kleindienst A, Hore N, Buchfelder M, Brandner S: Early CSF and serum S100B concentrations for outcome prediction in traumatic brain injury and subarachnoid hemorrhage. Clin Neurol Neurosurg 145:7983, 2016

    • Search Google Scholar
    • Export Citation
  • 20

    Kezuka D, Tkarada-Iemata M, Hattori T, Mori K, Takahashi R, Kitao Y, : Deletion of Atf6α enhances kainate-induced neuronal death in mice. Neurochem Int 92:6774, 2016

    • Search Google Scholar
    • Export Citation
  • 21

    King MD, Laird MD, Ramesh SS, Youssef P, Shakir B, Vender JR, : Elucidating novel mechanisms of brain injury following subarachnoid hemorrhage: an emerging role for neuroproteomics. Neurosurg Focus 28(1):E10, 2010

    • Search Google Scholar
    • Export Citation
  • 22

    Lennihan L, Mayer SA, Fink ME, Beckford A, Paik MC, Zhang H, : Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke 31:383391, 2000

    • Search Google Scholar
    • Export Citation
  • 23

    Li H, Yu JS, Zhang DD, Yang YQ, Huang LT, Yu Z, : Inhibition of the receptor for advanced glycation end-products (RAGE) attenuates neuroinflammation while sensitizing cortical neurons towards death in experimental subarachnoid hemorrhage. Mol Neurobiol 54:755767, 2017

    • Search Google Scholar
    • Export Citation
  • 24

    Nakahara T, Tsuruta R, Kaneko T, Yamashita S, Fujita M, Kasaoka S, : High-mobility group box 1 protein in CSF of patients with subarachnoid hemorrhage. Neurocrit Care 11:362368, 2009

    • Search Google Scholar
    • Export Citation
  • 25

    Park IS, Meno JR, Witt CE, Suttle TK, Chowdhary A, Nguyen TS, : Subarachnoid hemorrhage model in the rat: modification of the endovascular filament model. J Neurosci Methods 172:195200, 2008

    • Search Google Scholar
    • Export Citation
  • 26

    Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, : Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 298:636642, 1989

    • Search Google Scholar
    • Export Citation
  • 27

    Ramasamy R, Yan SF, Schmidt AM: Advanced glycation endproducts: from precursors to RAGE: round and round we go. Amino Acids 42:11511161, 2012

    • Search Google Scholar
    • Export Citation
  • 28

    Ramasamy R, Yan SF, Schmidt AM: RAGE: therapeutic target and biomarker of the inflammatory response—the evidence mounts. J Leukoc Biol 86:505512, 2009

    • Search Google Scholar
    • Export Citation
  • 29

    Raucci A, Cugusi S, Antonelli A, Barabino SM, Monti L, Bierhaus A, : A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J 22:37163727, 2008

    • Search Google Scholar
    • Export Citation
  • 30

    Rueffert H, Gumplinger A, Renner C, Dengl M, Reske A, Kaisers UX, : Search for genetic variants in the ryanodine receptor 1 gene in patients with symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurocrit Care 15:410415, 2011

    • Search Google Scholar
    • Export Citation
  • 31

    Shiba M, Suzuki H, Fujimoto M, Shimojo N, Imanaka-Yoshida K, Yoshida T, : Imatinib mesylate prevents cerebral vasospasm after subarachnoid hemorrhage via inhibiting tenascin-C expression in rats. Neurobiol Dis 46:172179, 2012

    • Search Google Scholar
    • Export Citation
  • 32

    Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, : Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg 76:571577, 1992

    • Search Google Scholar
    • Export Citation
  • 33

    Sokół B, Wąsik N, Jankowski R, Hołysz M, Mańko W, Juszkat R, : Increase of soluble RAGE in cerebrospinal fluid following subarachnoid haemorrhage. Biomed Res Int 2017:7931534, 2017

    • Search Google Scholar
    • Export Citation
  • 34

    Solenski NJ, Haley EC Jr, Kassell NF, Kongable G, Germanson T, Truskowski L, : Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med 23:10071017, 1995

    • Search Google Scholar
    • Export Citation
  • 35

    Sonobe M, Yamazaki T, Yonekura M, Kikuchi H: Small unruptured intracranial aneurysm verification study: SUAVe study, Japan. Stroke 41:19691977, 2010

    • Search Google Scholar
    • Export Citation
  • 36

    Suarez JI, Tarr RW, Selman WR: Aneurysmal subarachnoid hemorrhage. N Engl J Med 354:387396, 2006

  • 37

    Sugawara T, Ayer R, Jadhav V, Zhang JH: A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model. J Neurosci Methods 167:327334, 2008

    • Search Google Scholar
    • Export Citation
  • 38

    Suzuki H, Hasegawa Y, Chen W, Kanamaru K, Zhang JH: Recombinant osteopontin in cerebral vasospasm after subarachnoid hemorrhage. Ann Neurol 68:650660, 2010

    • Search Google Scholar
    • Export Citation
  • 39

    Suzuki H, Kanamaru K, Shiba M, Fujimoto M, Imanaka-Yoshida K, Yoshida T, : Cerebrospinal fluid tenascin-C in cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 23:310317, 2011

    • Search Google Scholar
    • Export Citation
  • 40

    Taki W, Sakai N, Suzuki H: Determinants of poor outcome after aneurysmal subarachnoid hemorrhage when both clipping and coiling are available: Prospective Registry of Subarachnoid Aneurysms Treatment (PRESAT) in Japan. World Neurosurg 76:437445, 2011

    • Search Google Scholar
    • Export Citation
  • 41

    Tang SC, Wang YC, Li YI, Lin HC, Manzanero S, Hsieh YH, : Functional role of soluble receptor for advanced glycation end products in stroke. Arterioscler Thromb Vasc Biol 33:585594, 2013

    • Search Google Scholar
    • Export Citation
  • 42

    Tang SC, Yeh SJ, Tsai LK, Hu CJ, Lien LM, Peng GS, : Cleaved but not endogenous secretory RAGE is associated with outcome in acute ischemic stroke. Neurology 86:270276, 2016

    • Search Google Scholar
    • Export Citation
  • 43

    Testai FD, Aiyagari V, Hillmann M, Amin-Hanjani S, Dawson G, Gorelick P: Proof of concept: endogenous antiangiogenic factors predict the occurrence of symptomatic vasospasm post subarachnoid hemorrhage. Neurocrit Care 15:416420, 2011

    • Search Google Scholar
    • Export Citation
  • 44

    Tokiyoshi K, Ohnishi T, Nii Y: Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage. Surg Neurol 36:112118, 1991

    • Search Google Scholar
    • Export Citation
  • 45

    Wang KC, Tang SC, Lee JE, Li YI, Huang YS, Yang WS, : Cerebrospinal fluid high mobility group box 1 is associated with neuronal death in subarachnoid hemorrhage. J Cereb Blood Flow Metab 37:435443, 2017

    • Search Google Scholar
    • Export Citation
  • 46

    Wermer MJ, van der Schaaf IC, Velthuis BK, Algra A, Buskens E, Rinkel GJ: Follow-up screening after subarachnoid haemorrhage: frequency and determinants of new aneurysms and enlargement of existing aneurysms. Brain 128:24212429, 2005

    • Search Google Scholar
    • Export Citation
  • 47

    Xiao L, Sun W, Lan W, Xiong Y, Duan Z, Zhang Z, : Correlation between cerebral microbleeds and S100B/RAGE in acute lacunar stroke patients. J Neurol Sci 340:208212, 2014

    • Search Google Scholar
    • Export Citation
  • 48

    Yan SF, Ramasamy R, Schmidt AM: Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging. Biochem Pharmacol 79:13791386, 2010

    • Search Google Scholar
    • Export Citation
  • 49

    Yang DB, Dong XQ, Du Q, Yu WH, Zheng YK, Hu W, : Clinical relevance of cleaved RAGE plasma levels as a biomarker of disease severity and functional outcome in aneurysmal subarachnoid hemorrhage. Clin Chim Acta 486:335340, 2018

    • Search Google Scholar
    • Export Citation
  • 50

    Yokota C, Minematsu K, Tomii Y, Naganuma M, Ito A, Nagasawa H, : Low levels of plasma soluble receptor for advanced glycation end products are associated with severe leukoaraiosis in acute stroke patients. J Neurol Sci 287:4144, 2009

    • Search Google Scholar
    • Export Citation
  • 51

    Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin MJ, Li H, : Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 370:10971109, 2003

    • Search Google Scholar
    • Export Citation
  • 52

    Zhao J, Zhou D, Guo J, Ren Z, Zhou L, Wang S, : Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 46:421428, 2006

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 25 25 25
Full Text Views 24 24 24
PDF Downloads 17 17 17
EPUB Downloads 0 0 0